Similarly, the learning and memory abilities of PD rats were significantly improved compared with those of the model group after EA, accompanied by increased BDNF expression levels [66–73], which may underlie the effectiveness of EA in the treatment of PD. The gene discussed is BDNF; the disease is Parkinson disease.